Advertisement

Transcutaneous Electrical Nerve Stimulation for Cancer Pain

  • Jeffrey LohEmail author
Chapter

Abstract

Transcutaneous electrical nerve stimulation (TENS) as a treatment modality for chronic pain has been present since the mid-1800s. TENS works through multiple methods, with possible release of cytokines and conduction blockade of the A-beta and A-delta nerve fibers. Few randomized controlled trials exist examining the effects of TENS on cancer pain; however initial studies show beneficial improvement in pain scores and quality of life in cancer patients. Like TENS, transcranial direct current stimulation (tDCS) and cranial electrotherapy stimulation (CES) are treatments that entail electrical stimulation to the cerebral cortex of the brain. Few studies exist on tDCS and CES for the treatment of cancer pain; however these two treatment modalities have shown benefit for the treatment of fibromyalgia, depression, and neuropathic pain.

Keywords

Cancer pain Transcutaneous electrical nerve stimulation Transcranial direct current stimulation Cranial electrotherapy stimulation Mechanism of action Outcomes 

References

  1. 1.
    Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155(3758):108–9.CrossRefGoogle Scholar
  2. 2.
    Sluka KA, Walsh D. Transcutaneious electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003;4(3):109–21.CrossRefGoogle Scholar
  3. 3.
    Salter MW, Henry JL. Evidence that adenosine mediates the depression of spinal dorsal horn neurons induced by peripheral vibration in the cat. Neuroscience. 1987;22(2):631–50.CrossRefGoogle Scholar
  4. 4.
    Marchand S, Li J, Charest J. Effects of caffeine on analgesia from transcutaneous electrical nerve stimulation. N Engl J Med. 1995;333:325–6.CrossRefGoogle Scholar
  5. 5.
    Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC, Hao JX, Terenius L. Effect of low- and high-frequency TENS on Met-enkephalin-Arg Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain. 1991;47(3):295–8.CrossRefGoogle Scholar
  6. 6.
    Leonard G, Goffaux P, Marchand S. Deciphering the role of endogenous opioids in high-frequency TENS using low and high doses of naloxone. Pain. 2010;151(1):215–9.  https://doi.org/10.1016/j.pain.2010.07.012. Epub 2010 Aug 21CrossRefPubMedGoogle Scholar
  7. 7.
    Kalra A, Urban MO, Sluka KA. Blockage of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J Pharmacol Exp Ther. 2001;298(1):257–63.PubMedGoogle Scholar
  8. 8.
    Hurlow A, Bennett MI, Robb KA, Johnson MI, Simpson KH, Oxberry SG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev. 2012;3:CD006276.  https://doi.org/10.1002/14651858.CD006276.pub3.CrossRefGoogle Scholar
  9. 9.
    Robb KA, Newham DJ, Williams JE. Transcutaneous electrical nerve stimulation vs. transcutaneous spinal electroanalgesia for chronic pain associated with breast cancer treatments. J Pain Symptom Manag. 2007;33(4):410–9.CrossRefGoogle Scholar
  10. 10.
    Gadsby JG, Franks A, Jarvis P, Dewhurst F. Acupuncture like transcutaneous electrical nerve stimulation within palliative care: a pilot study. Complement Ther Med. 1997;5:13–8.CrossRefGoogle Scholar
  11. 11.
    Bennett MI, Johnson MI, Brown S, Searle RD, Radford H, Brown JM. Feasibility study of transcutaneous electrical nerve stimulation (TENS) for cancer bone pain. J Pain. 2010;11(4):351–9.CrossRefGoogle Scholar
  12. 12.
    Loh J, Gulati A. The use of transcutaneous electrical nerve stimulation (TENS) in a major cancer center for the treatment of severe cancer-related pain and associated disability. Pain Med. 2013;  https://doi.org/10.1111/pme.12038. Epub ahead of printCrossRefGoogle Scholar
  13. 13.
    Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011;10(6):417–27.  https://doi.org/10.1038/nrd3455.CrossRefPubMedGoogle Scholar
  14. 14.
    Cramp FL, McCullough GR, Lowe AS, Walsh DM. Transcutaneous electric nerve stimulation: the effect of intensity on local and distal cutaneous blood flow and skin temperature in healthy subjects. Arch Phys Med Rehabil. 2002;83(1):5–9.CrossRefGoogle Scholar
  15. 15.
    Chen CC, Johnson MI, McDonough S, Cramp F. The effect of transcutaneous electrical nerve stimulation on local and distal cutaneous blood flow following a prolonged heat stimulus in healthy subjects. Clin Physiol Funct Imaging. 2007;27(3):154–61.CrossRefGoogle Scholar
  16. 16.
    O’Connell NE, Wand BM, Marston L, Spencer S, Desouza LH. Non-invasive brain stimulation techniques for chronic pain. A report of a Cochrane systematic review and meta-analysis. Eur J Phys Rehabil Med. 2011;47(2):309–26. Epub 2011 Apr 14PubMedGoogle Scholar
  17. 17.
    Lyon DE, Schubert C, Taylor AG. Pilot study of cranial stimulation for symptom management in breast cancer. Oncol Nurs Forum. 2010;37(4):476–83.  https://doi.org/10.1188/10.ONF.476-483.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Plow EB, Pascual-Leone A, Machado A. Brain stimulation in the treatment of chronic neuropathic and non-cancerous pain. J Pain. 2012;13(5):411–24.  https://doi.org/10.1016/j.jpain.2012.02.001. Epub 2012 Apr 7CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Rokyta R, Fricová J. Neurostimulation methods in the treatment of chronic pain. Physiol Res. 2012;61(Suppl 2):S23–31.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Queen’s Medical Center, Department of Anesthesiology & Pain ManagementHonoluluUSA

Personalised recommendations